Resultados de la búsqueda 81-90 of 2225 for cellulite

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to explore various biomarkers in the post-treatment tissue of patients who have responded to cancer therapy and compare it to the ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work in ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate molecular markers which might be a predictor of pancreatic cancer or precancer by analyzing the secretions (fluid) ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to compare the cosmetic outcome of Superomedial and Inferior Pedical Breast Reduction. A Study to Evaluate ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed or refractory Chronic Lymphocytic Leukemia ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the effectiveess of a new 3D ultrasound imaging technology combining B-mode, microvessel imaging, shear wave ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...